Cxcr4 antagonist treatment of hematopoietic cells

Details for Australian Patent Application No. 2001258110 (hide)

Owner The University of British Columbia Chemokine Therapeutics Corporation

Inventors Cashman, Johanne; Arab, Lakhdar; Tudan, Christopher R.; Salari, Hassan; Eaves, Connie J.; Saxena, Geeta; Clark-Lewis, Ian; Merzouk, Ahmed

Agent Spruson & Ferguson

Pub. Number AU-B-2001258110

PCT Pub. Number WO01/85196

Priority 60205467 19.05.00 US; 2305787 09.05.00 CA

Filing date 9 May 2001

Wipo publication date 20 November 2001

Acceptance publication date 19 October 2006

International Classifications

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

19 October 2006 Application Accepted

  Published as AU-B-2001258110

15 February 2007 Standard Patent Sealed

1 April 2010 Alteration of Name

  The name of the patentee has been altered to The University Of British Columbia; British Canadian Biosciences Corp. 2003 Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001258111

2001258109